62 studies found for:    cgms, type 2
Show Display Options
Rank Status Study
1 Completed Diabetes Mellitus Type 2 Basal Insulin Dosing Requirements Study
Condition: Type 2 Diabetes Mellitus
Intervention: Device: CGMS with an insulin pump using rapid acting insulin
2 Completed Blood Monitoring and Data Acquisition and Utilization in Patients With Type 2 Diabetes Treated With Insulin
Condition: Type 2 Diabetes Mellitus
Interventions: Other: Remote Blood Glucose Monitoring;   Other: Continuous Glucose Monitoring;   Other: SMBG;   Other: SMBG With Knowledge
3 Recruiting SMBG Protocols Predicting Glucose Levels in Senior Diabetics With CAD
Conditions: Diabetes Mellitus, Type 2;   Coronary Artery Disease
Interventions: Behavioral: SMBG;   Other: CGMS
4 Completed Aerobic Training, Aerobic-resistance Training and Glucose Profile (CGMS) in Type 2 Diabetes
Conditions: Diabetes Mellitus, Type 2;   Treatment;   Exercise
Interventions: Behavioral: Acute aerobic exercise;   Behavioral: Acute aerobic-resistance exercise
5 Suspended Comparing Internet Blood Glucose Monitoring System and Continuous Glucose Monitoring System
Condition: Type 2 Diabetes Mellitus
Interventions: Other: Remote Blood Glucose Monitoring;   Other: Continuous Glucose Monitoring
6 Completed Insulin Analogue With Continuous Glucose Monitoring System (CGMS) Measurement
Condition: Diabetes Mellitus Type 2
Intervention: Drug: Insulin glargine
7 Completed
Has Results
Comparing the Efficacy and Safety of Biphasic Insulin Aspart 30 and Biphasic Human Insulin 30 on Blood Sugar Control in Subjects With Type 2 Diabetes
Conditions: Diabetes;   Diabetes Mellitus, Type 2
Interventions: Drug: biphasic insulin aspart 30;   Drug: biphasic human insulin 30;   Drug: metformin
8 Completed
Has Results
24-Hour Glycemia: Rosiglitazone Versus Glimepiride In Type 2 Diabetes
Condition: Non-Insulin-Dependent Diabetes Mellitus
Interventions: Drug: rosiglitazone-metformin fixed dose combination;   Drug: metformin + glimepiride
9 Recruiting Comparison of Vildagliptin vs. Glimepiride on Glucose Variability in Metformin Uncontrolled Type 2 Diabetic Patients
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Vildagliptin;   Drug: Glimepiride;   Drug: Metformin
10 Completed
Has Results
This Study Is To Determine If Inhaled Insulin Is Effective In Treating Type 2 Diabetes Mellitus
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Insulin glargine;   Drug: Inhaled Insulin (Exubera)
11 Recruiting Effects of Vildagliptine and Glimepiride on Glucose Variability
Condition: Diabetes Mellitus, Non-Insulin-Dependent
Interventions: Drug: Glimepiride;   Drug: Vildagliptin
12 Unknown  Study of Combination Therapy of Gliclazide MR and Basal Insulin Versus Insulin Monotherapy to Treat Type 2 Diabetes
Condition: Type 2 Diabetes
Interventions: Drug: Gliclazide MR and Insulin Glargine Injection;   Drug: Biosynthetic Human Insulin Injection
13 Completed
Has Results
Exubera vs Lispro in a Lantus-based Regimen for Improved Glycemic Control in Type 2 Diabetes
Condition: Diabetes Mellitus
Interventions: Drug: Insulin Lispro;   Drug: Exubera
14 Completed
Has Results
Effects of Nateglinide on Postprandial Glucose Excursion by Restoring Early Phase Insulin Secretion
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Nateglinide;   Drug: Acarbose
15 Completed Continuous Glucose Monitoring System (CGMS) in Type 2 Diabetic Patients Inadequately Controlled by Metformine Monotherapy; Analyze of Glycemic Profile Before and After Association of Glimepiride
Condition: Diabetes Mellitus
Intervention: Drug: GLIMEPIRIDE
16 Unknown  Continuous Glucose Monitoring in Patients With Type 2 Diabetes
Condition: Diabetes Mellitus Type 2
Interventions: Device: Continuous Glucose Monitor;   Device: Glucometer
17 Completed
Has Results
A Clinical Trial Comparing the Efficacy and Safety of Exubera® and Lantus®
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Insulin Glargine (Lantus®);   Drug: Inhaled Human Insulin (Exubera®)
18 Completed
Has Results
Obstructive Sleep Apnea (OSA), Sleepiness, and Activity in Diabetes Management
Conditions: Sleep Apnea, Obstructive;   Diabetes Mellitus, Type 2
Interventions: Device: Continuous Positive Airway Pressure (CPAP);   Device: Sham- Continuous Positive Airway Pressure (Sham-CPAP)
19 Completed Comparison Safety and Efficacy of Basal Insulin Lantus® (Insulin Glargine) vs NPH Insulin in Combination With Oral Antidiabetic Drugs (OADs) in Patients With Diabetes Mellitus, Type 2 (DMT2)
Condition: Diabetes Mellitus, Type 2
Intervention: Drug: insulin glargine
20 Not yet recruiting Effects of Vildagliptin Versus Glibenclamide on Glycemia After Exercise in Patients With Type 2 Diabetes
Conditions: Diabetes Mellitus, Type 2;   Hypoglycemic Agents;   Diabetic Blood Glucose Monitoring;   Exercise
Interventions: Drug: MET + Vildagliptin Group;   Drug: MET + Glibenclamide Group

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years